ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,218 | -11.7% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,380 | +68900.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2 | +100.0% | 600 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 600 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | -50.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | 0.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | 0.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,000 | 0.0% | 600 | +20.0% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | -84.6% | 500 | -7.2% | 0.00% | -83.3% |
| Q2 2021 | $13,000 | -7.1% | 539 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $14,000 | -50.0% | 539 | 0.0% | 0.01% | -53.8% |
| Q4 2020 | $28,000 | +180.0% | 539 | +112.2% | 0.01% | +116.7% |
| Q3 2020 | $10,000 | – | 254 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |